
Business Lunch IV: Mycopreneurial Thought and Action ft. Dennis Walker
We're back with another debauched business lunch of epic proportion. Today our guest is Mr. Mycopreneur himself - Dennis Walker. We called well in advance to get a big table on the patio at Gjelina, the HOTTEST eatery cum founder hub in Venice, so we could talk in depth about the implications psychedelic grey-market offerings containing all sorts of unlabeled compounds and analogs in gas stations and head shops around the country, the deep seeded homo eroticism present in the stories of America’s proudest boy, and the experiences that brought Dennis to meet his fate as a kindhearted connector of all things mushroom. There is perhaps only one man who can say he woke up in a yurt at the Ojai Mushroom Summit, debated the Proud Boys founder Gavin McInnes, and sat down to debrief and break bread with two of the industry's most exciting unknown personalities (us DUH) all in the same 72 hour period. We couldn't be more grateful to have him. Follow Dennis on Instagram @mycopreneurofficial Visit his website at www.mycopreneur.com To support our work and get even more of the reports you love, visit our Patreon To follow us on instagram…follow us on Instagram Sources Albert Hofmann and Franz Troxler, "Esters of Indoles" (US Patent 3,075,992) [1963]. https://patents.google.com/patent/US3075992 Alexander Shulgin and Ann Shulgin, "TiHKAL: The Continuation" [1997] David E. Nichols and Stewart Frescas in Synthesis, "Improvements to the Synthesis of Psilocybin and a Facile Method for Preparing the O-Acetyl Prodrug of Psilocin" [1999]. https://doi.org/10.1055/s-1999-3490 Russell Hausfeld for Psymposia, "COMPASS Pathways' Psilocybin Patent Questioned by UK Patent Examiner" [2021]. https://psymposia.com/magazine/compass-pathways-psilocybin-patent-questioned-by-uk-patent-examiner/ United States Code, "21 U.S.C. § 802(32): Controlled Substance Analogue" https://www.law.cornell.edu/uscode/text/21/802 United States Code, "21 U.S.C. § 813: Treatment of Controlled Substance Analogues" https://www.law.cornell.edu/uscode/text/21/813 U.S. Food and Drug Administration, "Investigation of Illnesses: Diamond Shruumz-Brand Chocolate Bars, Cones, & Gummies (June 2024)" [2024]. https://www.fda.gov/food/outbreaks-foodborne-illness/investigation-illnesses-diamond-shruumz-brand-chocolate-bars-cones-gummies-june-2024 Disclaimer This podcast addresses sensitive subjects, including drugs, addiction, and related topics. The information presented is for educational purposes only and should not be construed as medical advice. The hosts and guests are not licensed medical professionals. Do not rely on any information discussed in this podcast to make decisions regarding your health or well-being without first consulting a qualified healthcare provider. Discussion of drugs, their effects, or methods of consumption does not imply endorsement, encouragement, or promotion by the producers, hosts, guests, or affiliated parties. The producers, hosts, guests, and affiliated parties are not liable for any damages arising from the use of this podcast. Engage with the content responsibly, critically, and with an open mind. If you or someone else is struggling with substance abuse or addiction, please seek professional help immediately.















